Perdoceo Beats Its Own Bar With 18.5% Adjusted EPS Growth, Guides Q4 Above Prior Year
PRDO is trading near its 52-week low of $26.41 (1.6% above the low) on elevated volume (1.9× avg).
Summary
Third-quarter EPS came in at 70c, while adjusted EPS rose 18.5% to $0.77 from $0.65, and adjusted operating income grew 8.4% to $66.1 million, with management saying operating performance was ahead of expectations. Revenue was the soft spot: up just 1.9% to $215.9 million, with CTU revenue flat at 0.3% growth and AIUS slightly negative, while USAHS carried the quarter at 9.8% growth. Total enrollments of 47,260 were up only 1.6%, and CTU enrollments actually slipped 0.5%. Full-year guidance of $3.15-$3.19 adjusted EPS and $260-$263 million adjusted operating income implies a Q4 step-up versus last year's $0.59 and $51.6 million. The board declared a $0.17 quarterly dividend payable December 11 to holders of record November 27, and the company bought back 0.6 million shares for $19.9 million in the quarter with $65.1 million left on the authorization. The South University deal, up to $224 million in cash, is now expected to close as early as April 2027 and is called immediately accretive to adjusted operating income starting in 2027.
At the time of this announcement, PRDO was trading at $26.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $26.41 to $38.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.